Skip to content

Identification and experimental validation of biomarkers associated with lipotoxicity in chronic obstructive pulmonary disease through transcriptomic and single-cell RNA sequencing analysis

Identification and experimental validation of biomarkers associated with lipotoxicity in chronic obstructive pulmonary disease through transcriptomic and single-cell RNA sequencing analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127736
Enrollment
Unknown
Registered
2026-07-06
Start date
2026-07-06
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

Healthy control group:None

Sponsors

Shanxi Bethune Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. COPD group (5 cases): Age 40–80 years, no gender restriction; meeting the Global Initiative for Chronic Obstructive Lung Disease (GOLD) diagnostic criteria: post-bronchodilator FEV1/FVC = 0.70, FEV1% predicted >= 80%); no history of chronic respiratory diseases; voluntary participation with signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Concurrent other respiratory diseases such as asthma, bronchiectasis, lung cancer, active pulmonary tuberculosis, interstitial lung disease, etc. 2.history of acute respiratory tract infection or acute exacerbation of COPD within the past 4 weeks; 3.concurrent severe cardiac, hepatic, or renal insufficiency (NYHA class III–IV heart failure, Child-Pugh class C liver disease, eGFR 10 mg/day for more than 2 weeks); 6.pregnant or lactating women; 7.history of psychiatric disorders or cognitive impairment that prevents compliance with the study.

Design outcomes

Primary

MeasureTime frame
Relative expression levels of APRT and S100A8 mRNA;

Secondary

MeasureTime frame
Area under the ROC curve (AUC);

Countries

China

Contacts

Public ContactLi Jing

Shanxi Bethune Hospital

ftilj119@163.com+86 351 837 9148

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026